News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2024
June 2024
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
SBIR podcast on funding opportunities that focus on pediatric and rare cancers – National Cancer Institute
Photo from sbir.cancer.gov
Jun 21, 2024, 09:55

SBIR podcast on funding opportunities that focus on pediatric and rare cancers – National Cancer Institute

National Cancer Institute posted on X:

“NEW Podcast Episode! Are you interested in funding opportunities that focus on pediatric and rare cancers? Listen to SBIR‘s Innovation Lab’s podcast to learn more.
Don’t forget to subscribe!”

View the article attached to the post.
Source: National Cancer Institute/X

cancer Medical podcast National Cancer Institute OncoDaily Oncology Pediatric cancer SBIR SBIR's Innovation Lab
Blog
Jun 26, 2024, 12:21
Karen Knudsen: Kicking off our American Cancer Society Cancer Action Network advocacy event
Societies
Jun 26, 2024, 12:19
Brilliant keynote lecture on KRAS inhibitors by Dr. Ryan Corcoran at ESMOGI24
Insight
Jun 26, 2024, 12:09
Myeloma Paper of the Day, June 26th, suggested by Robert Orlowski
Insight
Jun 26, 2024, 12:05
Piotr Wysocki: Osimertinib after radiochemotherapy improves PFS in EGFR-mutated NSCLC patients – but is it really what they need?
Blog
Jun 26, 2024, 11:45
Sachin Jain: What are your thoughts on how we came to devalue expertise as a society?
Blog
Jun 26, 2024, 11:16
Access to medicine is a human right - The Max Foundation
Blog
Jun 26, 2024, 11:01
Cancer Research Institute's virtual Patient Immunotherapy Summit
Blog
Jun 26, 2024, 10:24
Chandler Park: Which patients would you not give EV-Pembro for 1st line metastatic bladder cancer?
Insight
Jun 26, 2024, 09:54
Miguel Bronchud: How often is post-recurrence treatment reported in adjuvant and neoadjuvant oncology randomized clinical trials?
Blog
Jun 26, 2024, 09:38
Katia Roque: Two poster presentations about cervical cancer and GTN at ESMOgynae2024
Blog
Jun 26, 2024, 08:52
Richard Scolyer: Amazing advances over the past half century
Insight
Jun 26, 2024, 08:30
IMFINZI (durvalumab) showed improved EFS and OS for MIBC in NIAGARA Phase III trial